Advertisement

Topics

Solentim Company Profile

13:31 EST 11th December 2018 | BioPortfolio

Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow and facilitate cell line scale-up. The Cell Metric™ product range consists of bio-analytical imaging stations for clone screening and proof of monoclonality, clone growth and stability measurements. To find more information visit www.solentim.com


News Articles [2 Associated News Articles listed on BioPortfolio]

Solentim wins place in Deloitte UK Technology Fast 50

Solentim named as one of the top 50 fastest growing UK technologies companies of 2018

Solentim Wins Two Queen’s Awards for Enterprise

Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation Wimborne, UK, 8th October 2018 / Sciad Newswire / Solentim...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Solentim

Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedi...

More Information about "Solentim" on BioPortfolio

We have published hundreds of Solentim news stories on BioPortfolio along with dozens of Solentim Clinical Trials and PubMed Articles about Solentim for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solentim Companies in our database. You can also find out about relevant Solentim Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record